Corcept Therapeutics, Inc. (CORT)
113.88
-3.05
(-2.61%)
USD |
NASDAQ |
Aug 28, 16:00
113.50
-0.38
(-0.33%)
After-Hours: 20:00
Corcept Therapeutics Max Drawdown (5Y) : 71.85% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 71.85% |
| June 30, 2026 | 71.85% |
| May 31, 2026 | 71.85% |
| April 30, 2026 | 71.85% |
| March 31, 2026 | 71.85% |
| February 28, 2026 | 70.02% |
| January 31, 2026 | 69.59% |
| December 31, 2025 | 69.53% |
| November 30, 2025 | 45.91% |
| October 31, 2025 | 45.91% |
| September 30, 2025 | 45.91% |
| August 31, 2025 | 50.82% |
| July 31, 2025 | 51.14% |
| June 30, 2025 | 51.14% |
| May 31, 2025 | 51.14% |
| April 30, 2025 | 51.14% |
| March 31, 2025 | 56.86% |
| February 28, 2025 | 60.35% |
| January 31, 2025 | 60.35% |
| December 31, 2024 | 60.35% |
| November 30, 2024 | 60.35% |
| October 31, 2024 | 60.35% |
| September 30, 2024 | 60.35% |
| August 31, 2024 | 60.35% |
| July 31, 2024 | 60.35% |
| Date | Value |
|---|---|
| June 30, 2024 | 60.35% |
| May 31, 2024 | 61.61% |
| April 30, 2024 | 61.65% |
| March 31, 2024 | 61.65% |
| February 29, 2024 | 61.65% |
| January 31, 2024 | 61.65% |
| December 31, 2023 | 61.65% |
| November 30, 2023 | 61.65% |
| October 31, 2023 | 61.65% |
| September 30, 2023 | 61.65% |
| August 31, 2023 | 61.65% |
| July 31, 2023 | 61.65% |
| June 30, 2023 | 61.65% |
| May 31, 2023 | 61.65% |
| April 30, 2023 | 61.65% |
| March 31, 2023 | 61.65% |
| February 28, 2023 | 61.65% |
| January 31, 2023 | 61.65% |
| December 31, 2022 | 61.65% |
| November 30, 2022 | 61.65% |
| October 31, 2022 | 61.65% |
| September 30, 2022 | 61.65% |
| August 31, 2022 | 61.65% |
| July 31, 2022 | 61.65% |
| June 30, 2022 | 61.65% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Liquidia Corp. | 93.87% |
| Eli Lilly & Co. | 34.47% |
| Abeona Therapeutics, Inc. | 99.58% |
| Indivior Pharmaceuticals, Inc. | 96.00% |
| Crinetics Pharmaceuticals, Inc. | 58.40% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 32.90 |
| Beta (5Y) | 0.4488 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 60.26% |
| Historical Sharpe Ratio (5Y) | 0.6146 |
| Historical Sortino (5Y) | 0.9618 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.89% |